Nanobiotix S.A. (0QAV.L) LSE

7.40

-0.13(-1.73%)

Updated at August 19 08:18AM

Currency In EUR

Valuation

Market Cap141.8M
Enterprise Value142.96M
P/E Ratio-5.17
PEG Ratio0.06
Price/Sales Ratio-30.75
Price/Book Ratio-5.36
Enterprise/Revenue-30.85
Enterprise/EBITDA-5.81

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin5.87
Operating Margin5.89

Management Effectiveness

Return On Assets-1.01
Return On Equity1.56

Income Statement

Revenue-11.61M
Revenue/Share-0.25
Gross Profit0
EBITDA-61.62M
Net Income-68.13M
Diluted EPS-1.44

Balance Sheet

Total Cash49.74M
Total Cash/Share1.05
Total Debt50.9M
Total Debt/Equity-0.77
Current Ratio1.04
Book Value Per Share-1.39

Price History

52-Week Change69.98
52-Week High10.38
52-Week Low1.62
Moving Average 50 Days6.68
Moving Average 200 Days6.55

Statistics

Average Volume8,588
Shares Outstanding47.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A